Caspase-7 subunit p20
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain A; UniProt 34–231 Chain B; UniProt 232–336 Chain C; UniProt 34–231 Chain D; UniProt 232–336 | Not recorded | ACE-1MH-ASP-B3L-PHE-1U8 × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;1:1 dilution with 0.15 M sodium citrate, 1.6 M sodium formate, pH 5.0 | Resolution 2.65 Å R-free 0.243 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6CL1 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1F1J CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO Deposited 2000-05-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;30% PEG 4000, 0.1 M Na-citrate, 0.2 M ammonium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.35 Å R-free 0.263 |
| 1F1J CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO Deposited 2000-05-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;30% PEG 4000, 0.1 M Na-citrate, 0.2 M ammonium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.35 Å R-free 0.263 |
| 1F1J CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO Deposited 2000-05-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
Chain B
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
|
Not recorded | SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;30% PEG 4000, 0.1 M Na-citrate, 0.2 M ammonium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.35 Å R-free 0.263 |
| 1F1J CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO Deposited 2000-05-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
Chain B
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;30% PEG 4000, 0.1 M Na-citrate, 0.2 M ammonium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.35 Å R-free 0.263 |
| 1F1J CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO Deposited 2000-05-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
Chain B
2–303(302 aa)
Fragment:P20/P10 CATALYTIC DOMAIN
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;30% PEG 4000, 0.1 M Na-citrate, 0.2 M ammonium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.35 Å R-free 0.263 |
| 1GQF Crystal structure of human procaspase-7 Deposited 2001-11-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
47–303(257 aa)
Chain B
47–303(257 aa)
|
Mutation:C187A Mutation:C187A | SO4 SULFATE ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;293 K;50 MM MES, PH 5.6, 10 MM MAGNESIUM CHLORIDE, 100 MM AMMONIUM SULFATE, 20% (W/V) PEG 8000
|
Resolution 2.90 Å R-free 0.285 |
| 1I4O CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX Deposited 2001-02-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
24–303(280 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å R-free 0.260 |
| 1I4O CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX Deposited 2001-02-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
24–303(280 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å R-free 0.260 |
| 1I4O CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX Deposited 2001-02-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–303(280 aa)
Chain B
24–303(280 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å R-free 0.260 |
| 1I51 CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP Deposited 2001-02-23 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
51–198(148 aa)
Chain B
199–303(105 aa)
Chain C
51–198(148 aa)
Chain D
199–303(105 aa)
|
Mutation:D169A Mutation:D169A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;ammonium sulfate, PEG4000, Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.45 Å R-free 0.272 |
| 1K86 Crystal structure of caspase-7 Deposited 2001-10-23 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
51–303(253 aa)
Chain B
51–303(253 aa)
|
Mutation:C186A Mutation:C186A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;296 K;PEG 4000, sodium chloride, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 2.60 Å R-free 0.257 |
| 1K88 Crystal structure of procaspase-7 Deposited 2001-10-23 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
51–303(253 aa)
Fragment:procaspase-7
Chain B
51–303(253 aa)
Fragment:procaspase-7
|
Mutation:C186A Mutation:C186A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;296 K;lithium sulfate, sodium chloride, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 2.70 Å R-free 0.253 |
| 1KMC Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex Deposited 2001-12-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–303(303 aa)
Chain B
1–303(303 aa)
|
Mutation:C285A Mutation:C285A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.3;295 K;PEG 3000, Phosphate/citrate, NaCl, pH 4.3, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.90 Å R-free 0.275 |
| 1SHJ Caspase-7 in complex with DICA allosteric inhibitor Deposited 2004-02-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
50–303(254 aa)
Chain B
50–303(254 aa)
|
Mutation:D169A Mutation:D169A | SO4 SULFATE ION × 3 NXN 2-(2,4-DICHLORO-PHENOXY)-N-(2-MERCAPTO-ETHYL)-ACETAMIDE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;277 K;citrate, LiSO4, NaCl, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å R-free 0.287 |
| 1SHL CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR Deposited 2004-02-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
57–199(143 aa)
Chain A
210–303(94 aa)
Chain B
57–199(143 aa)
Chain B
210–303(94 aa)
|
Mutation:D192A Mutation:D192A Mutation:D192A Mutation:D192A | FXN 5-FLUORO-1H-INDOLE-2-CARBOXYLIC ACID-(2-MERCAPTO-ETHYL)-AMIDE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;277 K;citrate, lithium sulfate, sodium chloride, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.00 Å R-free 0.273 |
| 2QL5 Crystal Structure of caspase-7 with inhibitor AC-DMQD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.34 Å R-free 0.233 |
| 2QL7 Crystal Structure of Caspase-7 with inhibitor AC-IEPD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.40 Å R-free 0.237 |
| 2QL9 Crystal Structure of Caspase-7 with inhibitor AC-DQMD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.14 Å R-free 0.225 |
| 2QLB Crystal Structure of caspase-7 with inhibitor AC-ESMD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.25 Å R-free 0.223 |
| 2QLF Crystal Structure of Caspase-7 with inhibitor AC-DNLD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.80 Å R-free 0.229 |
| 2QLJ Crystal Structure of Caspase-7 with Inhibitor AC-WEHD-CHO Deposited 2007-07-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;298 K;14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.60 Å R-free 0.234 |
| 3EDR The crystal structure of caspase-7 in complex with Acetyl-LDESD-CHO Deposited 2008-09-03 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit (UNP residues 24 to 196)
Chain B
207–303(97 aa)
Fragment:P10 subunit (UNP residues 207 to 303)
Chain C
24–196(173 aa)
Fragment:P20 subunit (UNP residues 24 to 196)
Chain D
207–303(97 aa)
Fragment:P10 subunit (UNP residues 207 to 303)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;2.1M Sodium Formate,0.1M Sodium Citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.45 Å R-free 0.248 |
| 3H1P Mature Caspase-7 I213A with DEVD-CHO inhibitor bound to active site Deposited 2009-04-13 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
50–303(254 aa)
Chain B
50–303(254 aa)
|
Mutation:I213A Mutation:I213A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;14% PEG 3350, 300mM diammonium hydrogen citrate, 10mM guanidine hydrochloride, and 10mM DTT, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.61 Å R-free 0.251 |
| 3IBC Crystal Structure of Caspase-7 incomplex with Acetyl-YVAD-CHO Deposited 2009-07-15 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;14.5% PEG 3350, 0.3 M diammonium hydrogen citrate, 10mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.75 Å R-free 0.242 |
| 3IBF Crystal structure of unliganded caspase-7 Deposited 2009-07-15 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–196(173 aa)
Fragment:P20 subunit
Chain B
207–303(97 aa)
Fragment:P10 subunit
Chain C
24–196(173 aa)
Fragment:P20 subunit
Chain D
207–303(97 aa)
Fragment:P10 subunit
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;2.1M Sodium formate, 0.1M Sodium citrate pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å R-free 0.235 |
| 3R5K A designed redox-controlled caspase-7 Deposited 2011-03-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–303(303 aa)
Chain B
1–303(303 aa)
|
Mutation:R210C C246S Mutation:R210C C246S | FMT FORMIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;293 K;2.1M Formate, 100mM Citrate, 1.25mM Cystamine, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.86 Å R-free 0.251 |
| 4FDL Crystal structure of Caspase-7 Deposited 2012-05-28 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
2–303(302 aa)
Chain B
2–303(302 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.1 M sodium citrate, pH 5.0-5.7, 1.9 M sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.80 Å R-free 0.239 |
| 4FEA Crystal structure of CASPASE-7 in Complex with allosteric inhibitor Deposited 2012-05-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
57–303(247 aa)
Fragment:P20/P10 catalytic domain (UNP residues 57-303)
Chain B
57–303(247 aa)
Fragment:P20/P10 catalytic domain (UNP residues 57-303)
|
Not recorded | 0TE chloro{methyl hydrogenato(3-)-kappa~2~N,S [pyridin-2-yl(pyridin-2(1H)-ylidene-kappaN)methyl]carbonodithiohydrazonate}copper × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M sodium citrate, pH 5.0-5.7, 1.9 M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.79 Å R-free 0.286 |
| 4HQ0 Crystal Structure of mutant form of Caspase-7 Deposited 2012-10-25 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
47–303(257 aa)
Fragment:UNP residues 47-303
Chain B
47–303(257 aa)
Fragment:UNP residues 47-303
|
Mutation:D198A Mutation:D198A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;sodium acetate pH 4.6, sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.00 Å R-free 0.267 |
| 4HQR Crystal Structure of mutant form of Caspase-7 Deposited 2012-10-26 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
47–303(257 aa)
Fragment:UNP residues 47-303
Chain B
47–303(257 aa)
Fragment:UNP residues 47-303
|
Mutation:D198A Mutation:D198A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.6;293 K;sodium formate, pH 4.6, VAPOR DIFFUSION, temperature 293K
|
Resolution 3.00 Å R-free 0.253 |
| 4JB8 Caspase-7 in Complex with DARPin C7_16 Deposited 2013-02-19 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
24–198(175 aa)
Chain B
207–303(97 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.3;293.15 K;0.2M MgCl2, 100mM Tris, 9% PEG 1000, 9% PEG 8000, pH 8.3, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.70 Å R-free 0.194 |
| 4JJ8 Caspase-3 specific unnatural amino acid peptides Deposited 2013-03-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
57–303(247 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;295 K;0.15M Sodium citrate pH 4.0, 2.0 M Sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.94 Å R-free 0.216 |
| 4JJ8 Caspase-3 specific unnatural amino acid peptides Deposited 2013-03-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
57–303(247 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;295 K;0.15M Sodium citrate pH 4.0, 2.0 M Sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.94 Å R-free 0.216 |
| 4JR1 Human procaspase-7 bound to Ac-DEVD-CMK Deposited 2013-03-20 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
57–303(247 aa)
Fragment:protease domain (UNP residues 57-303)
Chain B
57–303(247 aa)
Fragment:protease domain (UNP residues 57-303)
|
Mutation:D198A Mutation:D198A | CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;10 mM Tris, pH 8.0, 2 mM DTT, 50 mM sodium chloride, 200 mM ammonium formate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.15 Å R-free 0.227 |
| 4JR2 Human procaspase-7/caspase-7 heterodimer bound to Ac-DEVD-CMK Deposited 2013-03-20 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
57–303(247 aa)
Fragment:protease domain (UNP residues 57-303)
Chain B
57–303(247 aa)
Fragment:protease domain (UNP residues 57-303)
|
Mutation:D198A Mutation:D198A | CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10 mM Tris, pH 8.0, 2 mM DTT, 50 mM sodium chloride, 200 mM sodium/potassium phosphate, 100 mM Bis-Tris propane, pH 6.5, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.65 Å R-free 0.197 |
| 4LSZ Caspase-7 in Complex with DARPin D7.18 Deposited 2013-07-23 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
24–198(175 aa)
Fragment:Caspase-7 subunit p20, UNP residues 24-198
Chain B
207–303(97 aa)
Fragment:Caspase-7 subunit p10, UNP residues 207-303
Chain C
24–198(175 aa)
Fragment:Caspase-7 subunit p20, UNP residues 24-198
Chain D
207–303(97 aa)
Fragment:Caspase-7 subunit p10, UNP residues 207-303
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.6;293.15 K;0.8M Sodium Formate, 100mM Tris, 13% PEG 4000, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 2.26 Å R-free 0.208 |
| 4ZVO Caspase-7 Variant 4 (V4) with reprogrammed substrate specificity due to Y230V/W232Y/S234V/Q276D substitutions bound to VEID inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–198(198 aa)
Fragment:UNP residues 34-231
Chain B
199–303(105 aa)
Fragment:UNP residues 232-336
Chain C
1–198(198 aa)
Fragment:UNP residues 34-231
Chain D
199–303(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230V, W232Y, S234V, Q276D Mutation:Y230V, W232Y, S234V, Q276D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;300 mM diammonium citrate, 14% PEG 3350, 10 mM GuHCl
|
Resolution 2.85 Å R-free 0.251 |
| 4ZVP Caspase-7 Variant 2 (V2) with reprogrammed substrate specificity due to Y230V/W232M/Q276C substitutions bound to DEVD inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
34–231(198 aa)
Fragment:UNP residues 34-231
Chain B
232–336(105 aa)
Fragment:UNP residues 232-336
Chain C
34–231(198 aa)
Fragment:UNP residues 34-231
Chain D
232–336(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230V/W232M/Q276C Mutation:Y230V/W232M/Q276C | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;300 mM diammonium citrate, 14% PEG 3350, 10 mM GuHCl, 20% glycerol
|
Resolution 2.50 Å R-free 0.224 |
| 4ZVQ Caspase-7 Variant 2 (V2) with reprogrammed substrate specificity due to Y230V/W232M/Q276C substitutions bound to VEID inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
34–231(198 aa)
Fragment:UNP residues 34-231
Chain B
232–336(105 aa)
Fragment:UNP residues 232-336
Chain C
34–231(198 aa)
Fragment:UNP residues 34-231
Chain D
232–336(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230V/W232M/Q276C Mutation:Y230V/W232M/Q276C | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;300 mM diammonium citrate, 14% PEG 3350, 10 mM GuHCl, 20% glycerol
|
Resolution 2.50 Å R-free 0.208 |
| 4ZVR Caspase-7 Variant 4 (V4) with reprogrammed substrate specificity due to Y230V/W232Y/S234V/Q276D substitutions bound to DEVD inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–198(198 aa)
Fragment:UNP residues 34-231
Chain B
199–303(105 aa)
Fragment:UNP residues 232-336
Chain C
1–198(198 aa)
Fragment:UNP residues 34-231
Chain D
199–303(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230V,W232Y,S234V,Q276D Mutation:Y230V,W232Y,S234V,Q276D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;300 mM diammonium citrate, 14% PEG 3350, 10 mM GuHCl, 20% glycerol
|
Resolution 2.30 Å R-free 0.224 |
| 4ZVS Caspase-7 Variant 1 (V1) with reprogrammed substrate specificity due to Y230A/W232M/S234N substitutions, bound to DEVD inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–198(198 aa)
Fragment:UNP residues 34-231
Chain B
199–303(105 aa)
Fragment:UNP residues 232-336
Chain C
1–198(198 aa)
Fragment:UNP residues 34-231
Chain D
199–303(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230A, W232M, S234N Mutation:Y230A, W232M, S234N | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277.15 K;300 mM Diammonium Hydrogren Citrate, 14% PEG 3350, 10 mM Guanidinium Chloride, 10 mM Dithiotheritol
|
Resolution 2.50 Å R-free 0.239 |
| 4ZVT Caspase-7 Variant 1 (V1) with reprogrammed substrate specificity due to Y230A/W232M/S234N substitutions, bound to VEID inhibitor. Deposited 2015-05-18 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–198(198 aa)
Fragment:UNP residues 34-231
Chain B
199–303(105 aa)
Fragment:UNP residues 232-336
Chain C
1–198(198 aa)
Fragment:UNP residues 34-231
Chain D
199–303(105 aa)
Fragment:UNP residues 232-336
|
Mutation:Y230A, W232M, S234N Mutation:Y230A, W232M, S234N | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277.15 K;300 mM Diammonium Hydrogen Citrate, 14% PEG 3350, 10 mM Guanidinium Chloride, 10 mM Dithiotheritol
|
Resolution 2.85 Å R-free 0.234 |
| 4ZVU Caspase-7 wild-type bound to the caspase-6 cognate tetrapeptide inhibitor Ac-VEID-cho Deposited 2015-05-18 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–198(198 aa)
Fragment:UNP residues 34-231
Chain B
199–303(105 aa)
Fragment:UNP residues 232-336
Chain C
1–198(198 aa)
Fragment:UNP residues 34-231
Chain D
199–303(105 aa)
Fragment:UNP residues 232-336
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277.15 K;300 mM Diammonium Hydrogen Citrate, 14% PEG 3350, 10 mM Guanidinium Chloride, 10 mM Dithiotheritol
|
Resolution 2.60 Å R-free 0.252 |
| 5IC6 Crystal structure of caspase-7 DEVE peptide complex Deposited 2016-02-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
1–198(198 aa)
Chain B
199–303(105 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2 M ammonium fluoride, 0.1 M sodium acetate pH 4.6, 20% (w/v) PEG 10000
|
Resolution 2.70 Å R-free 0.241 |
| 5IC6 Crystal structure of caspase-7 DEVE peptide complex Deposited 2016-02-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
1–198(198 aa)
Chain D
199–303(105 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2 M ammonium fluoride, 0.1 M sodium acetate pH 4.6, 20% (w/v) PEG 10000
|
Resolution 2.70 Å R-free 0.241 |
| 5K20 Caspase-7 S239E Phosphomimetic Deposited 2016-05-18 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
34–231(198 aa)
Chain B
232–336(105 aa)
Chain C
34–231(198 aa)
Chain D
232–336(105 aa)
|
Mutation:S272E Mutation:S272E | FMT FORMIC ACID × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;2.1 M Sodium Formate
100 mM Sodium Citrate
|
Resolution 2.20 Å R-free 0.228 |
| 5V6U Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-acetylphenyl)sulfanyl]benzoic acid Deposited 2017-03-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
34–336(303 aa)
Fragment:UNP residues 34-336
Chain B
34–336(303 aa)
Fragment:UNP residues 34-336
|
Not recorded | 8YM 2-[(2-acetylphenyl)sulfanyl]benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.7;295 K;1.9 M sodium formate, 0.1 M sodium citrate, pH 5.7
|
Resolution 2.80 Å R-free 0.245 |
| 5V6Z Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid Deposited 2017-03-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
34–336(303 aa)
Fragment:UNP residues 34-336
Chain B
34–336(303 aa)
Fragment:UNP residues 34-336
|
Not recorded | 8YJ 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.7;295 K;1.9 M sodium formate, 0.1 M sodium citrate, pH 5.0-5.7
|
Resolution 2.60 Å R-free 0.249 |
| 6CL2 Caspase-7 in complex with Ac-ATS009-KE Deposited 2018-03-01 | Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
34–231(198 aa)
Chain B
232–336(105 aa)
Chain C
34–231(198 aa)
Chain D
232–336(105 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;1:1 dilution with 0.15 M sodium citrate, 1.6 M sodium formate, pH 5.0.
|
Resolution 2.35 Å R-free 0.236 |
| 6X8J Caspase-7 in complex with ketomethylene inhibitor reveals tetrahedral adduct Deposited 2020-06-01 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
34–231(198 aa)
Fragment:p20 (UNP residues 34-231)
Chain B
34–231(198 aa)
Fragment:p20 (UNP residues 34-231)
Chain C
232–336(105 aa)
Fragment:p11 (UNP residues 232-336)
Chain D
232–336(105 aa)
Fragment:p11 (UNP residues 232-336)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.2;295 K;1:1 protein : 0.15 M sodium citrate, 1.4 M sodium formate
|
Resolution 2.60 Å R-free 0.211 |
| 6X8L Caspase-7 in complex with elongated ketomethylene inhibitor Deposited 2020-06-01 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
34–231(198 aa)
Fragment:p20 (UNP residues 34-231)
Chain B
34–231(198 aa)
Fragment:p20 (UNP residues 34-231)
Chain C
232–336(105 aa)
Fragment:p11 (UNP residues 232-336)
Chain D
232–336(105 aa)
Fragment:p11 (UNP residues 232-336)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;295 K;1:1 protein : 0.15 M sodium citrate, 1.45 M sodium formate
|
Resolution 2.45 Å R-free 0.215 |
| 7WZS Crystal structure of Chromobacterium violaceum effector CopC in complex with host calmodulin and caspase-7 Deposited 2022-02-19 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
24–303(280 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;100 mM Bis-Tris propane pH 7.5, 1.5 M lithium sulfate
|
Resolution 3.60 Å R-free 0.314 |
| 8DGZ Caspase-7 bound to substrate mimic and allosteric inhibitor Deposited 2022-06-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
2–303(302 aa)
Chain B
2–303(302 aa)
|
Not recorded | 8YJ 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.1 M sodium citrate and 2.1 M sodium formate
|
Resolution 2.80 Å R-free 0.254 |
| 8DJ3 Caspase-7 bound to novel allosteric inhibitor Deposited 2022-06-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
2–303(302 aa)
Chain B
2–303(302 aa)
|
Not recorded | SE1 2-[(2-{[(3s,5s,7s)-adamantan-1-yl]sulfamoyl}phenyl)sulfanyl]benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.9 M sodium formate, 0.1 M sodium citrate, pH 5.0-5.7
|
Resolution 3.20 Å R-free 0.249 |
46 other PDB entries and 54 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | CASP7_HUMAN |
| Isoform | P55210-3 |
| PDB entities | 1, 2 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–198; UniProt 34–231 Author chain C; PDBConstruct 1–198; UniProt 34–231 Author chain B; PDBConstruct 1–105; UniProt 232–336 Author chain D; PDBConstruct 1–105; UniProt 232–336 |